<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02401841</url>
  </required_header>
  <id_info>
    <org_study_id>Policlinico 12</org_study_id>
    <nct_id>NCT02401841</nct_id>
  </id_info>
  <brief_title>Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex</brief_title>
  <official_title>Resolution of Neuro-muscular Block in Great Obese Patients: Neostigmine vs Sugammadex</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Policlinico Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Policlinico Hospital</source>
  <brief_summary>
    <textblock>
      It is a observational prospective study. The aim of this study is to compare neostigmine vs
      sugammadex in the resolution of neuro-muscular blockade in great obese patients.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2015</start_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Differences in neuro-muscular block resolution time between two groups</measure>
    <time_frame>up to 36 months</time_frame>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Resolution of Neuromuscular Blockade</condition>
  <arm_group>
    <arm_group_label>Sugammadex</arm_group_label>
    <description>Patients treated with Sugammadex</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Neostigmine</arm_group_label>
    <description>Patients treated with Neostigmine</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Two different types of drug for resolution of neuro-muscular blockade</intervention_name>
    <arm_group_label>Sugammadex</arm_group_label>
    <arm_group_label>Neostigmine</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Great obese patients undergoing videolaparoscopic surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Great obese

          -  Videolaparoscopic surgery

        Exclusion Criteria:

          -  Age under 18

          -  No acceptation of informed consent

          -  New York Heart Association &gt; 2
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Davide Chiumello, MD</last_name>
    <email>chiumello@libero.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Fondazione IRCC Ca' Granda - Ospedale Maggiore Policlinico</name>
      <address>
        <city>Milan</city>
        <zip>20122</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Davide Chiumello, MD</last_name>
      <phone>+39 0255033237</phone>
      <email>chiumello@libero.it</email>
    </contact>
    <investigator>
      <last_name>Davide Chiumello, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2015</study_first_submitted>
  <study_first_submitted_qc>March 24, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 30, 2015</study_first_posted>
  <last_update_submitted>October 19, 2015</last_update_submitted>
  <last_update_submitted_qc>October 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 20, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Policlinico Hospital</investigator_affiliation>
    <investigator_full_name>Davide Chiumello</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

